CA2446427A1 - Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation - Google Patents

Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation Download PDF

Info

Publication number
CA2446427A1
CA2446427A1 CA002446427A CA2446427A CA2446427A1 CA 2446427 A1 CA2446427 A1 CA 2446427A1 CA 002446427 A CA002446427 A CA 002446427A CA 2446427 A CA2446427 A CA 2446427A CA 2446427 A1 CA2446427 A1 CA 2446427A1
Authority
CA
Canada
Prior art keywords
polypeptide
novx
nucleic acid
protein
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002446427A
Other languages
English (en)
Inventor
John P. Ii Alsobrook
David W. Anderson
Ferenc L. Boldog
Catherine E. Burgess
Stacie J. Casman
Schlomit R. Edinger
Karen Ellerman
Esha A. Gangolli
Valerie L. Gerlach
Linda Gorman
Erik Gunther
John L. Herrmann
Weizhen Ji
Denise M. Lepley
David A. Lewin
Li Li
John R. Macdougall
Uriel M. Malyankar
Peter D. Mezes
Muralidhara Padigaru
Meera Patturajan
John A. Peyman
Luca Rastelli
Daniel K. Rieger
Mark E. Rothenberg
Suresh G. Shenoy
Glennda Smithson
Kimberly A. Spytek
David J. Stone
Raymond J. Taupier, Jr.
Velizar T. Tchernev
Corine A. M. Vernet
Edward Z. Voss
Bryan D. Zerhusen
Haihong Zhong
Charles E. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2446427A1 publication Critical patent/CA2446427A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des séquences d'acide nucléique codant des polypeptides associés au récepteur couplé à la protéine G. L'invention concerne également des polypeptides codés par lesdites séquences d'acide nucléique, des anticorps qui se lient au polypeptide de façon immunospécifique, ainsi que des dérivés, variants, mutants, ou des fragments du polypeptide, polynucléotide, ou anticorps concernés. L'invention se rapporte en outre à des méthodes thérapeutiques, des méthodes diagnostiques et des méthodes de recherche permettant de diagnostiquer, traiter et prévenir des troubles impliquant un(e) quelconque de ces protéines et acides nucléiques humains.
CA002446427A 2001-05-03 2002-05-02 Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation Abandoned CA2446427A1 (fr)

Applications Claiming Priority (59)

Application Number Priority Date Filing Date Title
US28839501P 2001-05-03 2001-05-03
US60/288,935 2001-05-04
US28908701P 2001-05-07 2001-05-07
US60/289,087 2001-05-07
US28962001P 2001-05-08 2001-05-08
US28962101P 2001-05-08 2001-05-08
US60/289,621 2001-05-08
US60/289,620 2001-05-08
US28981701P 2001-05-09 2001-05-09
US28981801P 2001-05-09 2001-05-09
US60/289,817 2001-05-09
US60/289,818 2001-05-09
US29019401P 2001-05-11 2001-05-11
US60/290,194 2001-05-11
US29075301P 2001-05-14 2001-05-14
US60/290,753 2001-05-14
US29118901P 2001-05-15 2001-05-15
US60/291,189 2001-05-15
US29124301P 2001-05-16 2001-05-16
US60/291,243 2001-05-16
US29200101P 2001-05-18 2001-05-18
US60/292,001 2001-05-18
US29237401P 2001-05-21 2001-05-21
US60/292,374 2001-05-21
US29258701P 2001-05-22 2001-05-22
US60/292,587 2001-05-22
US29310701P 2001-05-23 2001-05-23
US60/293,107 2001-05-23
US29358901P 2001-05-24 2001-05-24
US60/293,589 2001-05-24
US29374701P 2001-05-25 2001-05-25
US60/293,747 2001-05-25
US29411001P 2001-05-29 2001-05-29
US60/294,110 2001-05-29
US29443401P 2001-05-30 2001-05-30
US60/294,434 2001-05-30
US31219201P 2001-08-14 2001-08-14
US60/312,192 2001-08-14
US31318701P 2001-08-17 2001-08-17
US31317301P 2001-08-17 2001-08-17
US60/313,173 2001-08-17
US60/313,187 2001-08-17
US31872801P 2001-09-12 2001-09-12
US31874401P 2001-09-12 2001-09-12
US60/318,744 2001-09-12
US60/318,728 2001-09-12
US33591001P 2001-11-15 2001-11-15
US60/335,910 2001-11-15
US33394201P 2001-11-28 2001-11-28
US33389101P 2001-11-28 2001-11-28
US60/333,891 2001-11-28
US60/333,942 2001-11-28
US34577602P 2002-01-03 2002-01-03
US60/345,776 2002-01-03
US34522002P 2002-01-04 2002-01-04
US60/345,220 2002-01-04
US13607102A 2002-05-01 2002-05-01
US10/136,071 2002-05-01
PCT/US2002/014341 WO2002090568A2 (fr) 2001-05-03 2002-05-02 Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation

Publications (1)

Publication Number Publication Date
CA2446427A1 true CA2446427A1 (fr) 2002-11-14

Family

ID=30119585

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002446427A Abandoned CA2446427A1 (fr) 2001-05-03 2002-05-02 Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation

Country Status (3)

Country Link
EP (1) EP1539806A2 (fr)
CA (1) CA2446427A1 (fr)
WO (1) WO2002090568A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002326367A1 (en) * 2001-09-05 2003-03-18 Eli Lilly And Company Lp mammalian proteins; related reagents
AU2003251673A1 (en) * 2002-07-31 2004-02-23 Bayer Healthcare Ag Sequence of a putative humain serine protease
AU2003280642A1 (en) * 2002-11-01 2004-05-25 Takeda Pharmaceutical Company Limited Apoptosis inducer

Also Published As

Publication number Publication date
EP1539806A2 (fr) 2005-06-15
WO2002090568A2 (fr) 2002-11-14
WO2002090568A3 (fr) 2005-04-21

Similar Documents

Publication Publication Date Title
US20050287564A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20060063200A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2486490A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
CA2442574A1 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
US20030185815A1 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
US20040002120A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1401858A2 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
US20030224982A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20040006205A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002090500A2 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
US20040014053A1 (en) Novel proteins and nucleic acids encoding same
US20060211031A1 (en) Novel proteins and nucleic acids encoding same
CA2446427A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation
US20040018594A1 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
WO2002050275A2 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
CA2442739A1 (fr) Nouveaux anticorps se liant a des polypeptides antigeniques, acides nucleiques codant pour ces antigenes, et procedes d'utilisation de ceux-ci
CA2447935A1 (fr) Nouveaux anticorps se fixant a des polypeptides antigeniques, acides nucleiques codant les antigenes et modes d'utilisation
US20040029790A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
CA2471480A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
WO2003064589A2 (fr) Polypeptides therapeutiques, acides nucleiques les codant et leurs methodes d'utilisation
CA2440345A1 (fr) Nouveaux anticorps se liant a des polypeptides antigeniques, acides nucleiques codant pour les antigenes et procedes d'utilisation
CA2485089A1 (fr) Polypeptides therapeutiques, acides nucleiques codant pour lesdits polypeptides et methodes d'utilisation
WO2002072770A2 (fr) Nouvelles proteines humaines, polynucleotides codant pour celles-ci et methodes d'utilisation de celles-ci
US20030087274A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20060210559A1 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use

Legal Events

Date Code Title Description
FZDE Discontinued